BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 11603673)

  • 1. Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome.
    Rizzo M; Ghert MA; Harrelson JM; Scully SP
    Clin Orthop Relat Res; 2001 Oct; (391):224-33. PubMed ID: 11603673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondrosarcoma of the pelvis. Prognostic factors for 67 patients treated with definitive surgery.
    Sheth DS; Yasko AW; Johnson ME; Ayala AG; Murray JA; Romsdahl MM
    Cancer; 1996 Aug; 78(4):745-50. PubMed ID: 8756367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor prognostic factors in chondrosarcoma of the locomotor system. Apropos of 180 cases].
    Ucla E; Tomeno B; Forest M
    Rev Chir Orthop Reparatrice Appar Mot; 1991; 77(5):301-11. PubMed ID: 1836882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic chondrosarcomas: surgical treatment options.
    Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
    Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of central conventional chondrosarcoma.
    Angelini A; Guerra G; Mavrogenis AF; Pala E; Picci P; Ruggieri P
    J Surg Oncol; 2012 Dec; 106(8):929-37. PubMed ID: 22649023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondrosarcoma of the scapula: long-term oncologic outcome.
    Pant R; Yasko AW; Lewis VO; Raymond K; Lin PP
    Cancer; 2005 Jul; 104(1):149-58. PubMed ID: 15895373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curettage of biopsy-diagnosed grade 1 periacetabular chondrosarcoma.
    Normand AN; Cannon CP; Lewis VO; Lin PP; Yasko AW
    Clin Orthop Relat Res; 2007 Jun; 459():146-9. PubMed ID: 17452919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of cryosurgery on treatment outcome of low-grade chondrosarcoma.
    Ahlmann ER; Menendez LR; Fedenko AN; Learch T
    Clin Orthop Relat Res; 2006 Oct; 451():201-7. PubMed ID: 16788412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grade 2 chondrosarcoma: stage I or stage II tumor?
    Reith JD; Horodyski MB; Scarborough MT
    Clin Orthop Relat Res; 2003 Oct; (415):45-51. PubMed ID: 14612628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: a population-based Scandinavian Sarcoma Group study of 106 patients.
    Widhe B; Bauer HC;
    J Thorac Cardiovasc Surg; 2009 Mar; 137(3):610-4. PubMed ID: 19258076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological and functional results of cryosurgical therapy of enchondromas and chondrosarcomas grade 1.
    van der Geest IC; de Valk MH; de Rooy JW; Pruszczynski M; Veth RP; Schreuder HW
    J Surg Oncol; 2008 Nov; 98(6):421-6. PubMed ID: 18668642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors.
    Almefty K; Pravdenkova S; Colli BO; Al-Mefty O; Gokden M
    Cancer; 2007 Dec; 110(11):2457-67. PubMed ID: 17894390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment and outcome of conventional pelvic chondrosarcoma.
    Donati D; El Ghoneimy A; Bertoni F; Di Bella C; Mercuri M
    J Bone Joint Surg Br; 2005 Nov; 87(11):1527-30. PubMed ID: 16260673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of intralesional surgery on treatment outcome of chondrosarcoma.
    Ozaki T; Lindner N; Hillmann A; Rödl R; Blasius S; Winkelmann W
    Cancer; 1996 Apr; 77(7):1292-7. PubMed ID: 8608505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of locally recurrent chondrosarcoma: Is extensive further surgery justified?
    Streitbuerger A; Ahrens H; Gosheger G; Henrichs M; Balke M; Dieckmann R; Hardes J
    J Bone Joint Surg Br; 2012 Jan; 94(1):122-7. PubMed ID: 22219259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic impact of the curettage of grade 2 central chondrosarcoma of the extremity.
    Cho WH; Song WS; Jeon DG; Kong CB; Koh JS; Kim JI; Lee SY
    Ann Surg Oncol; 2011 Dec; 18(13):3755-61. PubMed ID: 21611858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does local recurrence impact survival in low-grade chondrosarcoma of the long bones?
    Schwab JH; Wenger D; Unni K; Sim FH
    Clin Orthop Relat Res; 2007 Sep; 462():175-80. PubMed ID: 17514007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of intralesional curettage for low-grade chondrosarcoma of long bones.
    Hanna SA; Whittingham-Jones P; Sewell MD; Pollock RC; Skinner JA; Saifuddin A; Flanagan A; Cannon SR; Briggs TW
    Eur J Surg Oncol; 2009 Dec; 35(12):1343-7. PubMed ID: 19570648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do pathological fractures influence survival and local recurrence rate in bony sarcomas?
    Bramer JA; Abudu AA; Grimer RJ; Carter SR; Tillman RM
    Eur J Cancer; 2007 Sep; 43(13):1944-51. PubMed ID: 17698347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.